ANGLE Inks Deal for Advanced Cancer Sequencing Tech
PremiumCompany AnnouncementsANGLE Inks Deal for Advanced Cancer Sequencing Tech
2M ago
ANGLE plc Advances Cancer Diagnostics with NuProbe Pact
Premium
Company Announcements
ANGLE plc Advances Cancer Diagnostics with NuProbe Pact
2M ago
ANGLE plc Clinches Deal with Recursion Pharmaceuticals
Premium
Company Announcements
ANGLE plc Clinches Deal with Recursion Pharmaceuticals
2M ago
ANGLE plc Announces Major Share Ownership Shift
PremiumCompany AnnouncementsANGLE plc Announces Major Share Ownership Shift
4M ago
ANGLE plc Triumphs at Annual General Meeting
Premium
Company Announcements
ANGLE plc Triumphs at Annual General Meeting
4M ago
ANGLE plc Secures £9.3m for Cancer Diagnostics Growth
Premium
Company Announcements
ANGLE plc Secures £9.3m for Cancer Diagnostics Growth
5M ago
ANGLE plc Doubles Revenue and Expands Pharma Partnerships
PremiumCompany AnnouncementsANGLE plc Doubles Revenue and Expands Pharma Partnerships
5M ago
ANGLE plc Targets £10.56M Fundraise for Growth
Premium
Company Announcements
ANGLE plc Targets £10.56M Fundraise for Growth
5M ago
ANGLE’s Parsortix System Aids in Cancer Trial Predictions
Premium
Company Announcements
ANGLE’s Parsortix System Aids in Cancer Trial Predictions
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100